<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-BJ3UMSR5/8e4b6b25-bcad-4206-b551-f1223c241fb5/PDF"><dcterms:extent>3440 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-BJ3UMSR5/c637522c-236b-42cf-abf2-c4f25f223419/TEXT"><dcterms:extent>39 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-BJ3UMSR5"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2023</dcterms:issued><dc:creator>Hrvatin Stančič, Bor</dc:creator><dc:creator>Liović, Mirjana</dc:creator><dc:contributor>Liović, Mirjana</dc:contributor><dc:creator>Sorčan, Tjaša</dc:creator><dc:creator>Zemljič Jokhadar, Špela</dc:creator><dc:format xml:lang="sl">številka:9/10</dc:format><dc:format xml:lang="sl">letnik:92</dc:format><dc:format xml:lang="sl">str. 427-434</dc:format><dc:identifier>DOI:10.6016/ZdravVestn.3410</dc:identifier><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:176374275</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-BJ3UMSR5</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">bulozna epidermoliza</dc:subject><dc:subject xml:lang="sl">celične terapije</dc:subject><dc:subject xml:lang="en">cell therapies</dc:subject><dc:subject xml:lang="en">epidermolysis bullosa</dc:subject><dc:subject xml:lang="sl">iPS celice</dc:subject><dc:subject xml:lang="en">iPSC</dc:subject><dc:subject xml:lang="sl">koža</dc:subject><dc:subject xml:lang="en">skin</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Inducirane pluripotentne matične celice in možnosti njihove uporabe pri zdravljenju dednih bolezni kože| Induced pluripotent stem cells and their potential for the development of therapeutic approaches for hereditary skin disorders|</dc:title><dc:description xml:lang="sl">In 1962, Gurdon discovered that cell specialization is reversible; he replaced the nucleus in a frog egg cell with a nucleus from an intestinal cell, and the altered egg cell developed into a tadpole. In 2006, Yamanaka discovered how by using just a few genes, adult mouse cells could be reprogrammed into a state similar to embryonic cells. The cells obtained in this way were called induced pluripotent stem cells, which can develop into all types of cells in the body, thus being a prom-ising tool for various treatment approaches based on cell therapies. Gurdon and Yamanaka won the 2012 Nobel Prize in Physiology for discovering mature cells’ potential to be reprogrammed into a pluripotent state. In this paper, we will briefly review findings in this field, emphasizing the group of rare hereditary diseases of skin fragility</dc:description><dc:description xml:lang="sl">Leta 1962 je Gurdon odkril, da je specializacija celic reverzibilna; jedro v jajčni celici žabe je nadomestil z jedrom iz čre-vesne celice. Iz spremenjene jajčne celice se je razvil paglavec. Leta 2006 je Yamanaka odkril, kako je mogoče z uporabo le nekaj genov reprogramirati odrasle mišje celice v stanje, ki je podobno embrionalnim celicam. Tako pridobljene celice so poimenovali inducirane pluripotentne matične celice, ki se lahko razvijejo v vse vrste celic v telesu, zato so obetavno orodje za različne pristope zdravljenja, ki temeljijo na celični terapiji. Gurdon in Yamanaka sta za odkritje, da je mogoče dozorele celice reprogramirati v pluripotentno stanje, leta 2012 prejela Nobelovo nagrado za fiziologijo. V tem prispevku bomo prikazali kratek pregled dognanj na tem področju, pri čemer bomo poudarili področje skupine redkih dednih bolez-ni krhkosti kože</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-BJ3UMSR5"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-BJ3UMSR5" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-BJ3UMSR5/8e4b6b25-bcad-4206-b551-f1223c241fb5/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-BJ3UMSR5/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-BJ3UMSR5" /></ore:Aggregation></rdf:RDF>